RN Mobile Menu

Search form


Ankylosing Spondylitis

Ankylosing Spondylitis


Psoriatic spondyloarthritis forms part of the spondyloarthritis spectrum, between peripheral-only psoriatic arthritis and ankylosing spondylitis.


Secukinumab relieves the clinical signs and symptoms of ankylosing spondylitis at two years, shows a study published in the Annals of the Rheumatic Diseases.

TNF-α inhibitor treatment in PsA, RA and AS may be associated with a significant increase in total cholesterol, triglycerides and the atherogenic index. Statins with treatment lowered LDL levels.

In this article, we highlight some of the most important pharma reports presented at ACR 2016 this year.


Polish researchers writing in the journal Reumatologia outline algorithms used to assess cardiovascular disease risk in rheumatoid arthritis, PsA and AS patients.


In this slideshow, we summarize the newly approved indications for Amgen's new biosimilar, adalimumab-atto (Amjevita) and, we highlight key points as stated by Amgen researchers.


Chronic back pain may not be as it seems. Many patients suffer for years before being diagnosed with axial spondyloarthritis.


Subscribe to Ankylosing Spondylitis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.